Periosteum-covered ACI (ACI-P) versus collagen membrane ACI (ACI-C): A single-surgeon, large cohort analysis of clinical outcomes and graft survivorship

Introduction: Autologous chondrocyte implantation (ACI) has undergone several technical modifications. Objectives: To compare clinical outcomes and graft survivorship between ''first-generation'' periosteum-covered ACI (ACI-P) and ''second-generation'' collage...

Full description

Bibliographic Details
Main Authors: Liana Leja, MS, Tom Minas, MD, MS
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Journal of Cartilage & Joint Preservation
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S266725452100010X
_version_ 1818690203611561984
author Liana Leja, MS
Tom Minas, MD, MS
author_facet Liana Leja, MS
Tom Minas, MD, MS
author_sort Liana Leja, MS
collection DOAJ
description Introduction: Autologous chondrocyte implantation (ACI) has undergone several technical modifications. Objectives: To compare clinical outcomes and graft survivorship between ''first-generation'' periosteum-covered ACI (ACI-P) and ''second-generation'' collagen membrane ACI (ACI-C). Methods: A total of 400 consecutive ACI cases performed by a single surgeon were reviewed. Of the total, 200 were treated with ACI-P and 200 ACI-C. Patients with a minimum follow-up of 2 years were included (ACI-P, n = 112; ACI-C, n = 94). A separate long-term analysis was completed with a mean follow-up of 9 ± 1.8 years in the ACI-P group and 12 ± 2.2 years in the ACI-C group. Clinical outcomes and graft survivorship were compared at both follow-up intervals. Predictors of treatment failures and subsequent surgical procedures (SSPs) were identified. Results: Treatment failures were significantly greater among ACI-P cases compared to ACI-C, P = .007 with a greater proportion of cases with disease progression in the ACI-P cohort, P = .022. SSPs were greater in the ACI-P cohort, P < .001. Debridement for symptomatic hypertrophy was the most frequently performed SSP among ACI-P cases. ACI generation and prior marrow stimulation were significant predictors of treatment failures and SSPs. There were significant mean improvements in patient subjective responses within treatment groups. No differences in patient subjective responses were observed between ACI generations. Cumulative graft survivorship was greater in the ACI-C cohort (P = .024). Conclusions: The use of ACI-C improved clinical outcomes with a reduction in treatment failures, SSPs, and graft hypertrophy, allowing the surgeon to treat a greater number of bipolar and multiple lesion cases with similar functional outcomes when compared to ACI-P.
first_indexed 2024-12-17T12:22:16Z
format Article
id doaj.art-19672149724e4f3cb6cf91b437016296
institution Directory Open Access Journal
issn 2667-2545
language English
last_indexed 2024-12-17T12:22:16Z
publishDate 2021-06-01
publisher Elsevier
record_format Article
series Journal of Cartilage & Joint Preservation
spelling doaj.art-19672149724e4f3cb6cf91b4370162962022-12-21T21:48:54ZengElsevierJournal of Cartilage & Joint Preservation2667-25452021-06-0112100010Periosteum-covered ACI (ACI-P) versus collagen membrane ACI (ACI-C): A single-surgeon, large cohort analysis of clinical outcomes and graft survivorshipLiana Leja, MS0Tom Minas, MD, MS1Cartilage Repair Center, Paley Orthopedic &amp; Spine Institute, West Palm Beach, Florida, USA; Liana Leja, 412-527-2736, 901 45th Street, Kimmel Building, West Palm Beach, FL 33407.Cartilage Repair Center, Paley Orthopedic &amp; Spine Institute, Harvard Medical School, Boston, Massachusetts, West Palm Beach, Florida, USA,Introduction: Autologous chondrocyte implantation (ACI) has undergone several technical modifications. Objectives: To compare clinical outcomes and graft survivorship between ''first-generation'' periosteum-covered ACI (ACI-P) and ''second-generation'' collagen membrane ACI (ACI-C). Methods: A total of 400 consecutive ACI cases performed by a single surgeon were reviewed. Of the total, 200 were treated with ACI-P and 200 ACI-C. Patients with a minimum follow-up of 2 years were included (ACI-P, n = 112; ACI-C, n = 94). A separate long-term analysis was completed with a mean follow-up of 9 ± 1.8 years in the ACI-P group and 12 ± 2.2 years in the ACI-C group. Clinical outcomes and graft survivorship were compared at both follow-up intervals. Predictors of treatment failures and subsequent surgical procedures (SSPs) were identified. Results: Treatment failures were significantly greater among ACI-P cases compared to ACI-C, P = .007 with a greater proportion of cases with disease progression in the ACI-P cohort, P = .022. SSPs were greater in the ACI-P cohort, P < .001. Debridement for symptomatic hypertrophy was the most frequently performed SSP among ACI-P cases. ACI generation and prior marrow stimulation were significant predictors of treatment failures and SSPs. There were significant mean improvements in patient subjective responses within treatment groups. No differences in patient subjective responses were observed between ACI generations. Cumulative graft survivorship was greater in the ACI-C cohort (P = .024). Conclusions: The use of ACI-C improved clinical outcomes with a reduction in treatment failures, SSPs, and graft hypertrophy, allowing the surgeon to treat a greater number of bipolar and multiple lesion cases with similar functional outcomes when compared to ACI-P.http://www.sciencedirect.com/science/article/pii/S266725452100010XAutologous chondrocyte implantationGraft survivorshipPeriosteal hypertrophyChondral defectsOsteochondral defectsKnee
spellingShingle Liana Leja, MS
Tom Minas, MD, MS
Periosteum-covered ACI (ACI-P) versus collagen membrane ACI (ACI-C): A single-surgeon, large cohort analysis of clinical outcomes and graft survivorship
Journal of Cartilage & Joint Preservation
Autologous chondrocyte implantation
Graft survivorship
Periosteal hypertrophy
Chondral defects
Osteochondral defects
Knee
title Periosteum-covered ACI (ACI-P) versus collagen membrane ACI (ACI-C): A single-surgeon, large cohort analysis of clinical outcomes and graft survivorship
title_full Periosteum-covered ACI (ACI-P) versus collagen membrane ACI (ACI-C): A single-surgeon, large cohort analysis of clinical outcomes and graft survivorship
title_fullStr Periosteum-covered ACI (ACI-P) versus collagen membrane ACI (ACI-C): A single-surgeon, large cohort analysis of clinical outcomes and graft survivorship
title_full_unstemmed Periosteum-covered ACI (ACI-P) versus collagen membrane ACI (ACI-C): A single-surgeon, large cohort analysis of clinical outcomes and graft survivorship
title_short Periosteum-covered ACI (ACI-P) versus collagen membrane ACI (ACI-C): A single-surgeon, large cohort analysis of clinical outcomes and graft survivorship
title_sort periosteum covered aci aci p versus collagen membrane aci aci c a single surgeon large cohort analysis of clinical outcomes and graft survivorship
topic Autologous chondrocyte implantation
Graft survivorship
Periosteal hypertrophy
Chondral defects
Osteochondral defects
Knee
url http://www.sciencedirect.com/science/article/pii/S266725452100010X
work_keys_str_mv AT lianalejams periosteumcoveredaciacipversuscollagenmembraneaciacicasinglesurgeonlargecohortanalysisofclinicaloutcomesandgraftsurvivorship
AT tomminasmdms periosteumcoveredaciacipversuscollagenmembraneaciacicasinglesurgeonlargecohortanalysisofclinicaloutcomesandgraftsurvivorship